DIAMEDICA THERAPEUTICS INC's ticker is and the CUSIP is 25253X907. A total of 2 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,060 | -41.1% | 7,000 | -1.4% | 0.00% | – |
| Q2 2023 | $30,672 | +182.4% | 7,100 | 0.0% | 0.00% | – |
| Q1 2023 | $10,863 | +20.7% | 7,100 | +2.9% | 0.00% | – |
| Q3 2022 | $9,000 | -52.6% | 6,900 | -28.1% | 0.00% | – |
| Q2 2022 | $19,000 | +137.5% | 9,600 | +209.7% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 3,100 | +72.2% | 0.00% | – |
| Q4 2021 | $7,000 | -36.4% | 1,800 | -35.7% | 0.00% | – |
| Q3 2021 | $11,000 | +120.0% | 2,800 | +154.5% | 0.00% | – |
| Q2 2021 | $5,000 | – | 1,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 7,000 | $18,060 | 0.00% |